Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP504302.RAmJX0hRkHDZrae6GsYQ1_oMpAm4PRE8XVaSan3wx-hVs130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP504302.RAmJX0hRkHDZrae6GsYQ1_oMpAm4PRE8XVaSan3wx-hVs130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP504302.RAmJX0hRkHDZrae6GsYQ1_oMpAm4PRE8XVaSan3wx-hVs130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP504302.RAmJX0hRkHDZrae6GsYQ1_oMpAm4PRE8XVaSan3wx-hVs130_provenance.
- NP504302.RAmJX0hRkHDZrae6GsYQ1_oMpAm4PRE8XVaSan3wx-hVs130_assertion description "[Of 74 different genes identified as overexpressed in cancer tissues, several encode proteins with demonstrated clinical diagnostic application, such as alpha-fetoprotein in liver carcinoma, and kallikreins 6 and 10 in ovarian cancer, or therapeutic utility, such as gastrin-releasing peptide/bombesin in lung carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP504302.RAmJX0hRkHDZrae6GsYQ1_oMpAm4PRE8XVaSan3wx-hVs130_provenance.
- NP504302.RAmJX0hRkHDZrae6GsYQ1_oMpAm4PRE8XVaSan3wx-hVs130_assertion evidence source_evidence_literature NP504302.RAmJX0hRkHDZrae6GsYQ1_oMpAm4PRE8XVaSan3wx-hVs130_provenance.
- NP504302.RAmJX0hRkHDZrae6GsYQ1_oMpAm4PRE8XVaSan3wx-hVs130_assertion SIO_000772 12624183 NP504302.RAmJX0hRkHDZrae6GsYQ1_oMpAm4PRE8XVaSan3wx-hVs130_provenance.
- NP504302.RAmJX0hRkHDZrae6GsYQ1_oMpAm4PRE8XVaSan3wx-hVs130_assertion wasDerivedFrom befree-20140225 NP504302.RAmJX0hRkHDZrae6GsYQ1_oMpAm4PRE8XVaSan3wx-hVs130_provenance.
- NP504302.RAmJX0hRkHDZrae6GsYQ1_oMpAm4PRE8XVaSan3wx-hVs130_assertion wasGeneratedBy ECO_0000203 NP504302.RAmJX0hRkHDZrae6GsYQ1_oMpAm4PRE8XVaSan3wx-hVs130_provenance.
- befree-20140225 importedOn "2014-02-25" NP504302.RAmJX0hRkHDZrae6GsYQ1_oMpAm4PRE8XVaSan3wx-hVs130_provenance.